MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
28.73
-0.56 (-1.91%)
At close: May 15, 2026, 4:00 PM EDT
28.15
-0.58 (-2.02%)
After-hours: May 15, 2026, 7:54 PM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $1.3 billion as of May 15, 2026.
Market Cap
1.30B
Enterprise Value
998.26M
1-Year Change
n/a
Ranking
Category
Stock Price
$28.73
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $1.30B, an increase of 84.98%. That is a compound annual growth rate of 207.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.30B | 69.95% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 1.38B |
| GH Research | 1.38B |
| Biohaven | 1.36B |
| Bicara Therapeutics | 1.36B |
| Fortrea Holdings | 1.35B |
| AbCellera Biologics | 1.34B |
| MoonLake Immunotherapeutics | 1.34B |
| Savara | 1.34B |